Primary angioplasty versus prehospital fibrinolysis in acute myocardial infarction: a randomised study.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  The Lancet

• Publication date

  2002-09-14

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0140-6736(02)09963-4PMID 12243916
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Platelet glycoprotein IIb/IIIa inhibition with coronary stenting for acute myocardial infarction.

  2001cited by this paper
• Efficacy and safety of tenecteplase in combination with enoxaparin, abciximab, or unfractionated heparin: the ASSENT-3 randomised trial in acute myocardial infarction.

  2001cited by this paper
• Primary angioplasty versus intravenous thrombolysis in acute myocardial infarction: can we define subgroups of patients benefiting most from primary angioplasty? Results from the pooled data of the Maximal Individual Therapy in Acute Myocardial Infarction Registry and the Myocardial Infarction Regis

  2001cited by this paper
• Relationship of symptom-onset-to-balloon time and door-to-balloon time with mortality in patients undergoing angioplasty for acute myocardial infarction.

  2000cited by this paper
• Relation between hospital primary angioplasty volume and mortality for patients with acute MI treated with primary angioplasty vs thrombolytic therapy.

  2000cited by this paper
• Intracranial hemorrhage associated with thrombolytic therapy for elderly patients with acute myocardial infarction: results from the Cooperative Cardiovascular Project.

  2000cited by this paper
• Ten-year experience with early angioplasty in 759 patients with acute myocardial infarction.

  2000cited by this paper
• A matched comparison of the combination of prehospital thrombolysis and standby rescue angioplasty with primary angioplasty.

  1999cited by this paper
• Single-bolus tenecteplase compared with front-loaded alteplase in acute myocardial infarction: the ASSENT-2 double-blind randomised trial.

  1999cited by this paper
• Evaluation of a weight-adjusted single-bolus plasminogen activator in patients with myocardial infarction: a double-blind, randomized angiographic trial of lanoteplase versus alteplase.

  1998cited by this paper
• TNK-tissue plasminogen activator compared with front-loaded alteplase in acute myocardial infarction: results of the TIMI 10B trial. Thrombolysis in Myocardial Infarction (TIMI) 10B Investigators.

  1998cited by this paper
• Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review.

  1998cited by this paper
• Prehospital care in France, current status and international controversies

  1997cited by this paper
• A clinical trial comparing primary coronary angioplasty with tissue plasminogen activator for acute myocardial infarction.

  1997cited by this paper
• Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction : A quantitative review

  1997cited by this paper
• A comparison of thrombolytic therapy with primary coronary angioplasty for acute myocardial infarction. Myocardial Infarction Triage and Intervention Investigators.

  1996cited by this paper
• A Comparison of Thrombolytic Therapy with Primary Coronary Angioplasty for Acute Myocardial Infarction

  1996cited by this paper
• Randomized comparison of coronary thrombolysis achieved with double-bolus reteplase (recombinant plasminogen activator) and front-loaded, accelerated alteplase (recombinant tissue plasminogen activator) in patients with acute myocardial infarction. The RAPID II Investigators.

  1996cited by this paper
• Early thrombolytic treatment in acute myocardial infarction: reappraisal of the golden hour.

  1996cited by this paper
• 1999 update: ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction).

  1996cited by this paper
• Halving of mortality at 1 year by domiciliary thrombolysis in the Grampian Region Early Anistreplase Trial (GREAT).

  1994cited by this paper
• Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Fibrinolytic Therapy Trialists' (FTT) Collaborative Group.

  1994cited by this paper
• Randomized comparison of rescue angioplasty with conservative management of patients with early failure of thrombolysis for acute anterior myocardial infarction.

  1994cited by this paper
• Indications for fibrinolytic therapy in suspected acute myocardial infarction : collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients

  1994cited by this paper
• Prehospital thrombolytic therapy in patients with suspected acute myocardial infarction.

  1993cited by this paper
• The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction.

  1993cited by this paper
• Prehospital-initiated vs hospital-initiated thrombolytic therapy. The Myocardial Infarction Triage and Intervention Trial.

  1993cited by this paper
• A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. The Primary Angioplasty in Myocardial Infarction Study Group.

  1993cited by this paper
• A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction: Grines CL, Browne KF, Marco J, et al. N Engl J Med 328:673–679 Mar 1993

  1993cited by this paper
• Immediate angioplasty compared with the administration of a thrombolytic agent followed by conservative treatment for myocardial infarction. The Mayo Coronary Care Unit and Catheterization Laboratory Groups.

  1993cited by this paper
• A comparison of immediate coronary angioplasty with intravenous streptokinase in acute myocardial infarction.

  1993cited by this paper
• A Comparison of Immediate Angioplasty with Thrombolytic Therapy for Acute Myocardial Infarction

  1993cited by this paper

• CVIT expert consensus document on primary percutaneous coronary intervention (PCI) for acute coronary syndromes (ACS) in 2026.

  2026cites this paper
• Urgent thrombolysis followed by percutaneous coronary intervention for the simultaneous acute cardio-cerebral ischemic attack: A case report

  2025cites this paper
• CVIT expert consensus document on primary percutaneous coronary intervention (PCI) for acute coronary syndromes (ACS) in 2024

  2024cites this paper
• Effect of different reperfusion strategies on recovery of ventricular function after ST‐segment elevation myocardial infarction: A longitudinal single‐center study

  2024cites this paper
• The Future of Pharmacoinvasive Therapy for ST-Segment-Elevation Myocardial Infarction Reperfusion in the Post-STREAM Era.

  2024cites this paper
• Perspective/Commentary: The Transformation of STEMI Care with Thrombolysis in Paramedicine

  2024cites this paper
• Nitroglycerin use and adverse clinical outcomes in elderly patients with acute coronary syndrome

  2024cites this paper
• Strategy to Reduce Mortality Rates of ST-elevation Acute Myocardial Infarction Using Prehospital Thrombolysis: A Meta-analysis

  2024cites this paper
• Informing Utstein-style reporting guidelines for prehospital thrombolysis: A scoping review.

  2024cites this paper
• Role of ticagrelor in the peri-thrombolytic phase for patients with ST-segment elevation myocardial infarction: a comprehensive review

  2024cites this paper
• REVISÃO SISTEMÁTICA

  2024cites this paper
• Phenotyping heart failure by cardiac magnetic resonance imaging of cardiac macro- and microscopic structure: state of the art review

  2023cites this paper
• Relationship between Mean Platelet Volume and ST Segment Resolution after Reperfusion Therapy in Patients with ST Elevation Myocardial Infarction

  2023cites this paper
• 2023 ESC Guidelines for the management of acute coronary syndromes.

  2023cites this paper
• 2023 ESC Guidelines for the management of acute coronary syndromes.

  2023cites this paper
• Use of the Pharmacoinvasive Strategy in Argentina. ARGEN-IAM ST Registry Analysis

  2023cites this paper
• Benefit-risk balance of fibrinolytic therapy in ST-elevation myocardial infarction as evaluated by physicians.

  2023cites this paper
• In Hospital Outcome of Pharmaco-invasive Therapy versus Primary PCI In ST-segment elevation Myocardial Infarction in Dhaka, Bangladesh

  2023cites this paper
• Nitroglycerin use preceding primary percutaneous coronary intervention is associated with adverse clinical outcomes in elderly patients with acute coronary syndrome

  2023cites this paper
• CVIT expert consensus document on primary percutaneous coronary intervention (PCI) for acute myocardial infarction (AMI) update 2022

  2022cites this paper
• Correlation of Triglyceride/High Density Lipoprotein Cholesterol Ratio with Major Cardiovascular Events in Acute Coronary Syndrome within 30 Days Post Coronary Revascularization in Haji Adam Malik General Hospital of Medan

  2022cites this paper
• Late outcomes of ST-elevation myocardial infarction treated by pharmaco-invasive or primary percutaneous coronary intervention.

  2022cites this paper
• Influence of Total Ischemic Time on Clinical Outcomes in Patients with ST-Segment Elevation Myocardial Infarction.

  2021cites this paper
• Impact of Helicopter Transport on Reperfusion Times and Long-Term Outcomes in Acute Myocardial Infarction Patients in Rural Areas: A Report From the Mie Acute Coronary Syndrome Registry.

  2021cites this paper
• Fibrinolysis vs. primary percutaneous coronary intervention for ST‐segment elevation myocardial infarction cardiogenic shock

  2021cites this paper
• Primary Percutaneous Coronary Intervention in the Very Elderly: A Realistic Intervention?

  2021cites this paper
• Outcomes after delayed primary percutaneous coronary intervention vs. pharmaco-invasive strategy in ST-segment elevation myocardial infarction in Norway

  2021cites this paper
• Direct Admission of Patients With ST‐Segment–Elevation Myocardial Infarction to the Catheterization Laboratory Shortens Pain‐to‐Balloon and Door‐to‐Balloon Time Intervals but Only the Pain‐to‐Balloon Interval Impacts Short‐ and Long‐Term Mortality

  2020cites this paper
• Inferior ST-Elevation Myocardial Infarction Presenting When Urgent Primary Percutaneous Coronary Intervention Is Unavailable: Should We Adhere to Current Guidelines?

  2020cites this paper
• Systemic thrombolysis with tenecteplase in stent thrombosis patients as a life saving measure in odd situations: an observational study from tertiary care hospital

  2020cites this paper
• IAM

  2020cites this paper
• Long-Term Prognosis of Patients with Myocardial Infarction Type 1 and Type 2 with and without Involvement of Coronary Vasospasm

  2020cites this paper
• Clinical outcomes of patients after using prehospital fi brinolytic therapy: a systematic review

  2020cites this paper
• The Evolution of Coronary Intervention and Its Impact on Cardiac Arrhythmias

  2020cites this paper
• Residual platelet reactivity, thrombus burden and myocardial reperfusion in patients treated by PCI after successful pre-hospital fibrinolysis compared to primary PCI

  2020cites this paper
• Adding clinical value with coronary flow assessment in hypertrophic obstructive cardiomyopathy

  2020cites this paper
• Comparison of Reperfusion Strategies for ST‐Segment–Elevation Myocardial Infarction: A Multivariate Network Meta‐analysis

  2020cites this paper
• Desfechos clínicos de pacientes após uso de terapia fibrinolítica pré-hospitalar: revisão sistemática

  2020cites this paper
• Elderly Patients with ST-Segment Elevation Myocardial Infarction: A Patient-Centered Approach

  2019cites this paper
• 2019 Canadian Cardiovascular Society/Canadian Association of Interventional Cardiology Guidelines on the Acute Management of ST-Elevation Myocardial Infarction: Focused Update on Regionalization and Reperfusion.

  2019cites this paper
• 2018 ESC/EACTS Guidelines on myocardial revascularization.

  2019cites this paper
• Impact of living alone on the care and outcomes of patients with ST-elevation myocardial infarction.

  2019cites this paper
• Prevention of Cardiogenic Shock After Acute Myocardial Infarction.

  2019cites this paper
• Trends in clinical outcomes and survival following prehospital thrombolytic therapy given by ambulance clinicians for ST-elevation myocardial infarction in rural sub-arctic Norway

  2019cites this paper
• Guía ESC/EACTS 2018 sobre revascularización miocárdica

  2019cites this paper
• Impact of the Angioplasty Procedure in Cohort of the Patients Older than 80 Years with Anemia: An Observational Study

  2019cites this paper
• COMPARISON OF SURVIVAL TIMES AMONGST PATIENTS UNDERGOING PRIMARY PERCUTANEOUS CORONARY INTERVENTION, PHARMACO-INVASIVE AND THROMBOLYTIC THERAPY FOR ACUTE ST ELEVATION MYOCARIAL INFARCTION IN A TERTIARY CARE HOSPITAL: A SURVIVAL ANALYSIS

  2019cites this paper
• Primary PCI and the indistinct 120 min time limit.

  2019cites this paper
• Major Considerations and Success Score On the Angioplasty Procedure In a Cohort of Patients With Lower Heart Failure and Diabetes Mellitus

  2018cites this paper
• 2018 ESC/EACTS Guidelines on myocardial revascularization.

  2018cites this paper
• CVIT expert consensus document on primary percutaneous coronary intervention (PCI) for acute myocardial infarction (AMI) in 2018

  2018cites this paper
• Prehospital Diagnosis and Management of Acute Myocardial Infarction

  2018cites this paper
• Achieving the earliest possible reperfusion in patients with acute coronary syndrome: a current overview

  2018cites this paper
• Cost-Effectiveness of Recombinant HumanTNK Tissue-Type Plasminogen Activator(Rhtnk-Tpa) Versus Recombinant TissuePlasminogen Activator (Rt-PA) in Treating STElevationMyocardial Infarction (STEMI)

  2018cites this paper
• [2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation.]

  2018cites this paper
• 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC).

  2018cites this paper
• Primary Angioplasty

  2018cites this paper
• Fibrinolysis in Acute Myocardial Infarction ; State of the Art

  2018cites this paper
• Statistical Approach to Longitudinal Retrospective Study with Over 1,000 Participants Shows Main Predictors of Cardiovascular Disease for Angioplasty

  2018cites this paper
• [2018 ESC/EACTS Guidelines on myocardial revascularization].

  2018cites this paper
• 2018 ESC/EACTS Guidelines on myocardial revascularization.

  2018cites this paper
• OBSOLETE: STEMI: Management

  2018cites this paper
• Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction

  2018cites this paper
• Primary Percutaneous Coronary Intervention Versus In-hospital thrombolysis as Reperfusion Therapy in Early-Arriving Low-risk STEMI Patients.

  2017cites this paper
• of the Short-term Outcomes of Thrombolytics and Percutaneous Coronary Intervention in the Treatment of ST-segment Elevation Myocardial Infarction

  2017cites this paper
• Identifying patients with acute total coronary occlusion in NSTEACS: finding the high-risk needle in the haystack

  2017cites this paper
• Antithrombotic therapy before, during and after emergency angioplasty for ST elevation myocardial infarction

  2017cites this paper
• Synchronous cardiocerebral infarction in the era of endovascular therapy: which to treat first?

  2017influential citation
• Barriers Associated With Door-to-Balloon Delay in Contemporary Japanese Practice.

  2017cites this paper
• 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation.

  2017cites this paper
• Guía ESC 2017 sobre el tratamiento del infarto agudo de miocardio en pacientes con elevación del segmento ST

  2017cites this paper
• Pharmacoinvasive Management of STEMI

  2017cites this paper
• Reperfusion therapy of myocardial infarction in Mexico: A challenge for modern cardiology.

  2017cites this paper
• Temporal Trends of Reperfusion Strategies and Hospital Mortality for Patients With STEMI in Percutaneous Coronary Intervention-Capable Hospitals.

  2017cites this paper
• Comparing mortality between fibrinolysis and primary percutaneous coronary intervention in patients with acute myocardial infarction: a systematic review and meta-analysis of 27 randomized-controlled trials including 11 429 patients

  2017cites this paper
• Field triage in the ambulance versus referral via non-percutaneous coronary intervention centre in ST-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: A systematic review

  2017cites this paper
• Prognostic impact of non-compliance with guidelines-recommended times to reperfusion therapy in ST-elevation myocardial infarction. The FAST-MI 2010 registry

  2017cites this paper
• Onset-to-device time of patients who arrive at off-hours: Importance of prehospital management and public awareness for patients with ST-segment elevation myocardial infarction.

  2016cites this paper
• Bleeding events associated with fibrinolytic therapy and primary percutaneous coronary intervention in patients with STEMI

  2016cites this paper
• The Impact of Isolated Right Coronary Artery Angioplasty on Right Ventricular Functions in Patients with Unstable Angina Pectoris

  2016cites this paper
• Prehospital facilitated intervention as a potential “sally port” for the rescue of acute ST-segment elevation myocardial infarction: a meta-analysis

  2016cites this paper
• Epidemiology of Multimorbidity in Older Adults with Cardiovascular Disease.

  2016cites this paper
• Pathophysiology of ST-segment elevation myocardial infarction: novel mechanisms and treatments.

  2016cites this paper
• [Transport and treatment of patients with STEMI in rural Iceland--Only a few patients receive PPCI within 120 minutes].

  2016cites this paper
• Prognostic Impact of Chronic Total Occlusions: A Report From SCAAR (Swedish Coronary Angiography and Angioplasty Registry).

  2016cites this paper
• Drug Treatment of STEMI in the Elderly: Focus on Fibrinolytic Therapy and Insights from the STREAM Trial

  2016cites this paper
• Angioplastie coronaire, coronarographie et pontage aorto-coronarien en France : une approche géographique

  2016cites this paper
• Making of a highly useful multipurpose vaccine

  2016cites this paper
• Modélisation des stratégies de reperfusion de l’infarctus du myocarde

  2016cites this paper
• [Outcomes evaluation after the implementation of a pre-hospital thrombolysis protocol in rural areas].

  2016cites this paper
• The impact of a chronic total coronary occlusion on clinical outcome

  2016cites this paper
• Prehospital fibrinolysis versus primary percutaneous coronary intervention in ST-elevation myocardial infarction: a systematic review and meta-analysis of randomized controlled trials

  2016influential citation
• Grupo de Trabajo de Revascularización Miocárdica de la Sociedad Europea de Cardiología (ESC) y la European Association for Cardio-Thoracic Surgery (EACTS) Desarrollada con la colaboración especial de la European Association of Percutaneous Cardiovascular Interventions (EAPCI)

  2016cites this paper
• Percutaneous Coronary Intervention in the United States: Risk Factors for Untimely Access.

  2016cites this paper
• Low dose tenecteplase restores vessel patency in a clinically relevant porcine animal model

  2016cites this paper
• Impact of a pharmacoinvasive strategy when delays to primary PCI are prolonged

  2015cites this paper
• Part 9: Acute Coronary Syndromes: 2015 American Heart Association Guidelines Update for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.

  2015cites this paper
• Traducción oficial autorizada al español del Consejo Español de Resucitación Cardiopulmonar (CERCP)

  2015cites this paper
• Efficacy of Low Dose Tenecteplase in Restoring Vessel Patency in a Clinically Relevant Large Animal Experimental Model

  2015cites this paper
• Regional systems-of-care for primary percutaneous coronary intervention in ST-elevation myocardial infarction.

  2015cites this paper